Artz Cure Sarcoma was founded in 2015 by Zulema Arroyo-Farley following her own sarcoma diagnosis. It is dedicated to raising capital and creating awareness to find treatment options for what will hopefully lead to a cure in the future. We support the Soft-Tissue Sarcoma Research Laboratory at the MD Anderson Cancer Center in Houston, headed by Dr. Keila Enid Torres, M.D. Ph.D, Principal Investigator Soft-Tissue Sarcoma.
Sarcoma is a malignant tumor of connective tissue or other non-epithelial tissue. There are more than 50 types of soft tissue sarcoma; they are all rare and require expert diagnosis by a specialized sarcoma oncologist. MD Anderson’s Sarcoma Center is the nation’s largest program for bone and soft tissue sarcomas and their patients have a 80% five year survival rate.
Sarcoma lacks the intensive scrutiny devoted to other forms of cancer, hence the stinging absence of funds. In the U.S., it represents 15,000 (0.009%) of the 1,685,000 total cases of cancer that will be diagnosed this year. Consequently, resources for cancer research are allocated to combating more common forms of cancer resulting in very limited treatment options for sarcoma patients. Sarcoma, nonetheless, remains the one of the deadliest forms of cancer for children and adults.
Zulema Arroyo- Farley is a leading figure in the fight against sarcoma. In 2015, her activism inspired pop superstar Adele to invite Zulema on stage and applaud her efforts before 30,000 fans. In September 2015, Zulema was named one of the 25 Mujeres Poderosas ("25 Most Powerful Woman") by People en Español magazine for her restless efforts to create sarcoma awareness. Zulema and Artz Cure Sarcoma have also been the subject of numerous articles around the world including her native Puerto Rico. Fundraising is primarily driven by auctions featuring global established and emerging artists. Artz Cure Sarcoma is based in New York City.